|Bid||10,340.00 x 0|
|Ask||11,660.00 x 0|
|Day's range||10,557.10 - 10,700.00|
|52-week range||8,214.00 - 11,886.00|
|Beta (5Y monthly)||0.23|
|PE ratio (TTM)||103.13|
|Earnings date||09 Feb 2023|
|Forward dividend & yield||2.22 (2.09%)|
|Ex-dividend date||11 Aug 2022|
|1y target est||122.06|
Astrazeneca (AZN) closed the most recent trading day at $65.53, moving -0.7% from the previous trading session.
As far as life goals go, defeating cancer might be deemed one of the more fanciful.
AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.